Clinical Trials
2
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects
Recruiting
- Conditions
- MDD
- Interventions
- Drug: Pharmacokinetic profiles of Selegiline TDS and EMSAM
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Corium Innovations, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT06607744
- Locations
- 🇲🇾
Hospital Ampang, Pandan Mewah, Ampang, Malaysia
🇲🇾Sarawak General Hospital, Samoran, Sarawak, Malaysia
Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects
Recruiting
- Conditions
- Multiple SclerosisUlcerative Colitis
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Corium Innovations, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT06528665
- Locations
- 🇲🇾
Hospital Ampang, Ampang, Selangor, Malaysia
News
No news found